| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +66.67% | +51.33% | +1.38% | +49.95% | -1.75% | — |
| 14d | 3 | +66.67% | +51.89% | +1.43% | +50.46% | +9.46% | — |
| 30d | 3 | +66.67% | +35.94% | +2.30% | +33.64% | +17.94% | — |
| 60d | 3 | +66.67% | +76.53% | +4.30% | +72.23% | +35.43% | — |
| 90d | 3 | +33.33% | +72.92% | +4.62% | +68.30% | -10.67% | — |
| 180d | 3 | +33.33% | -43.00% | +11.01% | -54.01% | -98.33% | — |
| 1y | 3 | +0.00% | -87.95% | +26.98% | -114.93% | -123.85% | — |
| 2y | 3 | +0.00% | -99.95% | +42.65% | -142.59% | -143.62% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 9,761 | — | — | 9,761 | Nov 17, 2025 | Nov 19, 2025 ↗ | View → |
| MBRX MOLECULIN BIOTECH, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 165,169 | Nov 12, 2025 | Nov 14, 2025 ↗ | View → |
| MBRX MOLECULIN BIOTECH, INC. | PURCHASEGRANT Stock grant | 10,000 | — | — | 15,169 | Nov 4, 2024 | Nov 6, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 83,000 | — | — | 559,533 | Apr 8, 2024 | Apr 10, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 83,000 | — | — | 476,533 | Apr 8, 2024 | Apr 10, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 166,666 | — | — | 393,533 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 166,666 | — | — | 226,867 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 166,666 | $0.30 | $50.0K | 215,676 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 2,750 | $1.80 | $4.9K | 49,010 | Aug 16, 2023 | Aug 16, 2023 ↗ | View → |
| MBRX MOLECULIN BIOTECH, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 77,501 | May 25, 2023 | May 26, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | SALE Chief Executive Officer | 1,250 | — | — | 60,201 | Apr 28, 2023 | May 1, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 1,250 | — | — | 46,260 | Apr 28, 2023 | May 1, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASE Chief Executive Officer | 15,000 | $0.69 | $10.4K | 45,010 | Apr 12, 2023 | Apr 14, 2023 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 16,467 | — | — | 61,451 | Mar 29, 2023 | Mar 31, 2023 ↗ | View → |
| MBRX MOLECULIN BIOTECH, INC. | PURCHASEGRANT Stock grant | 23,333 | — | — | 47,501 | Jun 20, 2022 | Jun 22, 2022 ↗ | View → |
| MBRX MOLECULIN BIOTECH, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 62,501 | Jun 20, 2022 | Jun 22, 2022 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 600,000 | — | — | 1,349,500 | Apr 28, 2022 | Apr 29, 2022 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 35,000 | $0.28 | $9.8K | 940,298 | Mar 7, 2022 | Mar 8, 2022 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 5,000 | $1.28 | $6.4K | 905,298 | Nov 16, 2021 | Nov 18, 2021 ↗ | View → |
| MBRX MOLECULIN BIOTECH, INC. | PURCHASEGRANT Stock grant | 10,000 | — | — | 24,168 | Jun 7, 2021 | Jun 9, 2021 ↗ | View → |
| CNSP CNS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 310,000 | — | — | 749,500 | Feb 5, 2021 | Feb 9, 2021 ↗ | View → |
| MBRX MOLECULIN BIOTECH, INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 85,000 | Jun 15, 2020 | Jun 17, 2020 ↗ | View → |